1. Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma. (5th November 2016) Authors: de Greef, R; Elassaiss‐Schaap, J; Chatterjee, M; Turner, DC; Ahamadi, M; Forman, M; Cutler, D; de Alwis, DP; Kondic, A; Stone, J Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. Issue 10 (16th September 2008) Authors: Weihl, C C; Temiz, P; Miller, S E; Watts, G; Smith, C; Forman, M; Hanson, P I; Kimonis, V; Pestronk, A Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 79:Issue 10(2008) Page Start: 1186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗